Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 5, 2015Radiology

Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy

View Full Paper
Ask AI
Bookmark
Share

Authors

TKTomonori KandaShiga University of Medical ScienceTFToshio FukusatoTeikyo UniversityMMMegumi MatsudaMemorial Hospital

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kanda et al. (2015) studied this question.

synapsesocial.com/papers/69d7263c8a0e2c5879bef9dehttps://doi.org/10.1148/radiol.2015142690
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comparison of Gd(DTPA-BMA) (Omniscan) Versus Gd(HP-DO3A) (ProHance) Relative to Gadolinium Retention in Human Bone Tissue by Inductively Coupled Plasma Mass Spectroscopy2006 · 362 citations
  2. 2Progressive Increase of T1 Signal Intensity of the Dentate Nucleus on Unenhanced Magnetic Resonance Images Is Associated With Cumulative Doses of Intravenously Administered Gadodiamide in Patients With Normal Renal Function, Suggesting Dechelation2014 · 420 citations
  3. 3MRI contrast agents: Basic chemistry and safety2012 · 335 citations
  4. 4Role of thermodynamic and kinetic parameters in gadolinium chelate stability2009 · 201 citations
  5. 5Multiorgan gadolinium (Gd) deposition and fibrosis in a patient with nephrogenic systemic fibrosis--an autopsy-based review2011 · 101 citations